Chantal Visser, MD

PhD candidate, MD
Department of Hematology, Erasmus MC, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands

My name is Chantal Visser (MD) and I am currently a second year PhD candidate at the department of hematology of the Erasmus MC, Erasmus University Medical Center in Rotterdam in the Netherlands. The topics of my research include the treatment and quality of vitamin K antagonists and COVID-19 associated thrombosis. During the ISTH congress, I will present the preliminary results of our study concerning the effect of COVID-19 vaccination in young adults and adolescents.

Presentation(s):

• PB0078 - Lupus anticoagulant as predictor for thrombosis in critically ill COVID-19 patients: a retrospective cohort study

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• OC 39.5 - The immediate effect of COVID-19 vaccination on anticoagulation control in adolescents and young adults using vitamin K antagonists.

  Monday, July 11, 2022
  11:45 AM – 12:00 PM

• PB0592 - Altered Fibrin Network Structure and Fibrinolysis in Intensive Care Unit Patients with COVID-19, Not Entirely Explaining the Increased Risk of Thrombosis

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0593 - Increased Percentage of Extended Aα Chain Fibrinogen (αE) in COVID-19 Patients

  Monday, July 11, 2022
  6:30 PM – 7:30 PM